博济医药携子公司与欧洲Pharmaxi达成战略合作

Core Viewpoint - The strategic collaboration between Boji Pharmaceutical, its subsidiary BlOTrialMed, and European CRO Pharmaxi aims to provide a comprehensive "China-US-Europe" cross-regional clinical trial solution for Chinese biopharmaceutical companies [1] Group 1 - Boji Pharmaceutical has announced a strategic partnership with BlOTrialMed and Pharmaxi [1] - The collaboration will integrate Boji's full-process R&D capabilities with BlOTrialMed's North American clinical service advantages and Pharmaxi's localized resources in Europe [1] - This partnership is designed to offer a one-stop solution for clinical trials across multiple regions [1]